Table 4.
Patient ID | Gene | Transcript | Genotype | Variant type | AA change | rs ID | CADD | ACMG/ClinVar | GnomAD-AF | Additional variant |
---|---|---|---|---|---|---|---|---|---|---|
HCM-80 | MYL2 | NM_000432 | Het | Missense | Ex5:p.(Gly92Ala) | NA | 25.2 | VUS/NA | NA | Unique variant |
HCM-77 | MYL3 | NM_000258 | Hom | Missense | Ex3:p.(Ala57Asp) | rs139794067 | 29.8 | VUS/Conflicting | 0.0001627 | Unique variant |
HCM-78 | MYL3 | NM_000258 | Het | Missense | Ex3:p.(Arg94Cys) | rs730880961 | 33 | VUS/VUS | 0.00002388 | Unique variant |
HCM-79 | MYL3 | NM_000258 | Het | Missense | Ex5:p.(Arg163Thr) | rs752165383 | 25.0 | VUS/VUS | 0.000003998 | Unique variant |
AA, amino acid; ACMG, American College of Medical Genetics and Genomics; Het, heterozygous; Hom, homozygous; VUS, variant of uncertain significance; NA, no data available; Conflicting, conflicting interpretations of pathogenicity; CADD, combined annotation-dependent depletion scores according to CADD model v1.3; GnomAD-AF, allele frequency according to gnomAD V2.1.